Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research
- PMID: 19966936
- PMCID: PMC2776290
Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research
Abstract
Several challenges face the development and operation of a biospecimen bank linked to clinical information, a critical component of any effective translational research program. Melanoma adds particular complexity and difficulty to such an endeavor considering the unique characteristics of this malignancy. We describe here a review of biospecimen bank and our experience in establishing a multi-disciplinary, prospective, integrated clinicopathological-biospecimen database in melanoma. The Interdisciplinary Melanoma Cooperative Group (IMCG), a prospective clinicopathological and biospecimen database, was established at the New York University (NYU) Langone Medical Center. With patients' informed consent, biospecimens from within and outside NYU, clinicopathological data, and follow-up information are collected using developed protocols. Information pertaining to biospecimens is recorded in 35 fields, and clinicopathological information is recorded in 371 fields within 5 modules in a virtual network system. Investigators conducting research utilizing the IMCG biospecimen resource are blind to clinicopathological information, and molecular data generated using biospecimens are linked independently with clinicopathological data by biostatistics investigators. This translational research enterprise acts as a valuable resource to efficiently translate laboratory discoveries to the clinic.
Keywords: Melanoma; clinical database; model; specimen bank; translational medicine.
Similar articles
-
Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer.Ann Surg Oncol. 2008 May;15(5):1356-66. doi: 10.1245/s10434-008-9833-1. Epub 2008 Feb 7. Ann Surg Oncol. 2008. PMID: 18256882
-
National Mesothelioma Virtual Bank: a standard based biospecimen and clinical data resource to enhance translational research.BMC Cancer. 2008 Aug 13;8:236. doi: 10.1186/1471-2407-8-236. BMC Cancer. 2008. PMID: 18700971 Free PMC article.
-
Generation and validation of a universal perinatal database and biospecimen repository: PeriBank.J Perinatol. 2016 Nov;36(11):921-929. doi: 10.1038/jp.2016.130. Epub 2016 Sep 15. J Perinatol. 2016. PMID: 27629376
-
Developments in biospecimen research.Br Med Bull. 2015 Jun;114(1):29-38. doi: 10.1093/bmb/ldv012. Epub 2015 Apr 24. Br Med Bull. 2015. PMID: 25913285 Review.
-
A Federated Network for Translational Cancer Research Using Clinical Data and Biospecimens.Cancer Res. 2015 Dec 15;75(24):5194-201. doi: 10.1158/0008-5472.CAN-15-1973. Cancer Res. 2015. PMID: 26670560 Free PMC article. Review.
Cited by
-
Serum microRNAs as biomarkers for recurrence in melanoma.J Transl Med. 2012 Aug 2;10:155. doi: 10.1186/1479-5876-10-155. J Transl Med. 2012. PMID: 22857597 Free PMC article.
-
Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient Cohort.J Invest Dermatol. 2022 Oct;142(10):2733-2743.e9. doi: 10.1016/j.jid.2022.03.031. Epub 2022 Apr 22. J Invest Dermatol. 2022. PMID: 35469904 Free PMC article.
-
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy.J Transl Med. 2014 Dec 10;12:342. doi: 10.1186/s12967-014-0342-7. J Transl Med. 2014. PMID: 25491880 Free PMC article.
-
ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas.Cancer Res. 2015 Sep 1;75(17):3554-67. doi: 10.1158/0008-5472.CAN-14-2959. Epub 2015 Jul 23. Cancer Res. 2015. PMID: 26206558 Free PMC article.
-
PP6C hotspot mutations in melanoma display sensitivity to Aurora kinase inhibition.Mol Cancer Res. 2014 Mar;12(3):433-9. doi: 10.1158/1541-7786.MCR-13-0422. Epub 2013 Dec 12. Mol Cancer Res. 2014. PMID: 24336958 Free PMC article.
References
-
- Ries LAG MD, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Horner MJ, Howlader N, Eisner MP, Reichman M, Edwards BK, editors. SEER Cancer Statistics Review, 1975–2004. Bethesda, MD: National Cancer Institute; 2007. http://seer.cancer.gov/csr/1975_2004/, based on November 2006 SEER data submission, posted to the SEER web site.
-
- Jensen E, Margolin KA, Sondak VK. Melanoma and Other Skin Cancers. In: Pazdur R CL, Hoskins WJ, Wagman LD, editors. Cancer Management: A Multidisciplinary Approach. 10 ed. The Oncology Group; 2007. p. Chapter 23.
-
- Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med. 2004;351:998–1012. - PubMed
-
- The Lewin Group, Inc. The burden of skin diseases 2004. Cleveland: The Society of Investigative of Dermatology and the The American Academy of Dermatology Association; 2004. Skin cancer, precancerous conditions, and benign neoplasms; pp. 23–28.
-
- Tsao H, Rogers GS, Sober AJ. An estimate of the annual direct cost of treating cutaneous melanoma. J Am Acad Dermatol. 1998;38:669–80. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources